Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report 2026
Download Free Sample Buy Now
Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report 2026

By Vaccine Type (Messenger Ribonucleic Acid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Viral Vector Vaccines, Protein Subunit Vaccines, Peptide Vaccines, Other Vaccine Types), By Technology or Platform (Lipid Nanoparticle (LNP) Delivery, Self-Amplifying Messenger Ribonucleic Acid, Circular Messenger Ribonucleic Acid, Replicon or Non-replicating Platforms, Viral Vector Technologies), By Disease Indication (Infectious Diseases, Oncology, Rare Diseases, Other Disease Indications), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes, Hospitals and Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

• Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms market size has reached to $39.69 billion in 2025

• Expected to grow to $82.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%

• Growth Driver: Increasing Demand For Personalized Medicine Is Fueling The Growth Of The Market Due To Rising Adoption Of Precision Therapies

• Market Trend: Advancements In mRNA And Next-Generation Vaccine Platforms Strengthen COVID-19 Immunization Strategies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market?

Messenger ribonucleic acid (mRNA) and next-generation vaccine platforms refer to advanced vaccine technologies that use genetic instructions, such as mRNA, DNA, or viral vectors, to stimulate the body’s immune system to produce protective proteins and generate immunity against diseases. These platforms enable faster vaccine development, high adaptability to emerging pathogens, scalable manufacturing, and improved immune responses compared to traditional vaccine approaches.

The main vaccine types of messenger ribonucleic acid (mRNA) and next-generation vaccine platforms include messenger ribonucleic acid Vaccines, deoxyribonucleic acid (DNA) vaccines, viral vector vaccines, protein subunit vaccines, peptide vaccines, and other vaccine types. Messenger ribonucleic acid (mRNA) vaccines refer to vaccines that use synthetic mRNA sequences to instruct cells to produce specific antigens, thereby triggering an immune response against a target pathogen or disease. These platforms use technologies such as lipid nanoparticle (LNP) delivery, self-amplifying messenger ribonucleic acid (saRNA), circular messenger ribonucleic acid (circRNA), replicon or non-replicating platforms, and viral vector technologies. They are applied for disease indications including infectious diseases, oncology, rare diseases, and other disease indications, and are used by end users including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, and hospitals and clinics.

Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report bar graph

What Is The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size and Share 2026?

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market size has grown rapidly in recent years. It will grow from $39.69 billion in 2025 to $45.88 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to covid 19 vaccine breakthroughs, prior viral vector research, global pandemic preparedness programs, advances in genomic sequencing, early nucleic acid vaccine trials.

What Is The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Growth Forecast?

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market size is expected to see rapid growth in the next few years. It will grow to $82.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growth of personalized cancer vaccines, expansion of infectious disease pipelines, faster platform based approvals, increased biotech funding, broader therapeutic vaccine use. Major trends in the forecast period include self amplifying mrna platforms, lipid nanoparticle delivery optimization, modular vaccine platform design, rapid pathogen target adaptation, next generation adjuvant systems.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Segmentation

1) By Vaccine Type: Messenger Ribonucleic Acid Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Viral Vector Vaccines; Protein Subunit Vaccines; Peptide Vaccines; Other Vaccine Types

2) By Technology or Platform: Lipid Nanoparticle (LNP) Delivery; Self-Amplifying Messenger Ribonucleic Acid; Circular Messenger Ribonucleic Acid; Replicon or Non-replicating Platforms; Viral Vector Technologies

3) By Disease Indication: Infectious Diseases; Oncology; Rare Diseases; Other Disease Indications

4) By End User: Pharmaceutical and Biotechnology Companies; Contract Research Organizations (CROs); Academic and Research Institutes; Hospitals and Clinics

Subsegments:

1) By Messenger Ribonucleic Acid Vaccines: Conventional Messenger Ribonucleic Acid Vaccines; Self Amplifying Messenger Ribonucleic Acid Vaccines; Modified Messenger Ribonucleic Acid Vaccines; Circular Messenger Ribonucleic Acid Vaccines

2) By Deoxyribonucleic Acid Vaccines: Plasmid Deoxyribonucleic Acid Vaccines; Viral Assisted Deoxyribonucleic Acid Vaccines; Synthetic Deoxyribonucleic Acid Vaccines; Gene Based Deoxyribonucleic Acid Vaccines

3) By Viral Vector Vaccines: Adenovirus Based Viral Vector Vaccines; Lentivirus Based Viral Vector Vaccines; Poxvirus Based Viral Vector Vaccines; Measles Virus Based Viral Vector Vaccines

4) By Protein Subunit Vaccines: Recombinant Protein Vaccines; Virus Like Particle Vaccines; Toxoid Based Protein Vaccines; Polysaccharide Conjugate Vaccines

5) By Peptide Vaccines: Synthetic Peptide Vaccines; Personalized Peptide Vaccines; Multi Epitope Peptide Vaccines; Long Peptide Vaccines

6) By Other Vaccine Types: Protein Subunit Vaccines, Virus-Like Particle Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vector Vaccines

What Is The Driver Of The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market?

The increasing demand for personalized medicine is expected to propel the growth of the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market going forward. Personalized medicine is a medical approach in which disease prevention and treatment strategies are tailored based on an individual’s genetic profile, molecular characteristics, and specific health conditions. The rise in demand for personalized medicine is due to the growing prevalence of complex and chronic diseases, as these conditions require targeted and patient-specific therapeutic solutions to improve treatment efficacy and safety outcomes. Messenger ribonucleic acid (mRNA) and next-generation vaccine platforms support personalized medicine by enabling rapid, flexible, and highly specific vaccine and therapeutic designs that can be customized to individual genetic and disease profiles, supporting precision-based healthcare delivery. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms industry.

Key Players In The Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

Major companies operating in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms market are Pfizer Inc., Sanofi S.A., AstraZeneca PLC, Thermo Fisher Scientific Inc., GSK plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc, Acuitas Therapeutics Inc, and Incepta Vaccine Ltd.

Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Trends and Insights

Major companies operating in the mRNA and next-generation vaccine platforms market are focusing on developing next-generation mRNA-based COVID-19 vaccines to enhance immune durability, broaden variant coverage, and improve overall vaccine performance. Next-generation mRNA-based COVID-19 vaccines leverage improved mRNA engineering and delivery technologies to provide broader and more durable protection against existing and emerging SARS-CoV-2 variants and enhance safety, stability, and storage convenience while allowing rapid adaptation to viral evolution. For instance, in June 2025, Moderna Inc., a US-based biotechnology company, introduced mNEXSPIKE, its next-generation COVID-19 vaccine designed to improve protection against circulating and emerging SARS-CoV-2 variants. The vaccine incorporates an updated spike protein antigen that more closely matches recent variants and aims to deliver enhanced immune durability and effectiveness, supporting ongoing COVID-19 prevention efforts and future booster strategies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market?

In July 2024, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, partnered with CureVac N.V. to advance next-generation mRNA vaccines and accelerate development. The partnership aims to fortify GlaxoSmithKline's vaccine pipeline by gaining strategic control over next-generation mRNA programs and expediting their development and commercialization. CureVac N.V. is a Germany-based biotechnology company that specializes in next-generation messenger ribonucleic acid-based Covid and flu vaccines.

Regional Insights

North America was the largest region in the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market?

The messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market includes sales of messenger ribonucleic acid vaccines, lipid nanoparticle delivery systems, viral vector vaccines, protein subunit vaccines, recombinant antigen vaccines, next-generation adjuvants, synthetic ribonucleic acid constructs, stabilized messenger ribonucleic acid formulations, immune response modulators, and nucleic acid-based vaccine platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report 2026?

The messenger ribonucleic acid (mrna) and next-generation vaccine platforms market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $45.88 billion
Revenue Forecast In 2035 $82.61 billion
Growth Rate CAGR of 15.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Vaccine Type, Technology or Platform, Disease Indication, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Sanofi S.A., AstraZeneca PLC, Thermo Fisher Scientific Inc., GSK plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc, Acuitas Therapeutics Inc, and Incepta Vaccine Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Self Amplifying Mrna Platforms

4.2.2 Lipid Nanoparticle Delivery Optimization

4.2.3 Modular Vaccine Platform Design

4.2.4 Rapid Pathogen Target Adaptation

4.2.5 Next Generation Adjuvant Systems

5. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies

5.2 Contract Research Organizations (Cros)

5.3 Academic And Research Institutes

5.4 Hospitals And Clinics

5.5 Government Vaccine Programs

6. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size, Comparisons And Growth Rate Analysis

7.3. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Segmentation

9.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Messenger Ribonucleic Acid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Viral Vector Vaccines, Protein Subunit Vaccines, Peptide Vaccines, Other Vaccine Types

9.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lipid Nanoparticle (LNP) Delivery, Self-Amplifying Messenger Ribonucleic Acid, Circular Messenger Ribonucleic Acid, Replicon or Non-replicating Platforms, Viral Vector Technologies

9.3. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Diseases, Oncology, Rare Diseases, Other Disease Indications

9.4. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes, Hospitals and Clinics

9.5. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Messenger Ribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conventional Messenger Ribonucleic Acid Vaccines, Self Amplifying Messenger Ribonucleic Acid Vaccines, Modified Messenger Ribonucleic Acid Vaccines, Circular Messenger Ribonucleic Acid Vaccines

9.6. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Deoxyribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plasmid Deoxyribonucleic Acid Vaccines, Viral Assisted Deoxyribonucleic Acid Vaccines, Synthetic Deoxyribonucleic Acid Vaccines, Gene Based Deoxyribonucleic Acid Vaccines

9.7. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Viral Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenovirus Based Viral Vector Vaccines, Lentivirus Based Viral Vector Vaccines, Poxvirus Based Viral Vector Vaccines, Measles Virus Based Viral Vector Vaccines

9.8. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Protein Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Protein Vaccines, Virus Like Particle Vaccines, Toxoid Based Protein Vaccines, Polysaccharide Conjugate Vaccines

9.9. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Peptide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Synthetic Peptide Vaccines, Personalized Peptide Vaccines, Multi Epitope Peptide Vaccines, Long Peptide Vaccines

9.10. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Subunit Vaccines, Virus-Like Particle Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vector Vaccines

10. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Regional And Country Analysis

10.1. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

11.1. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

12.1. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

13.1. India Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

14.1. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

15.1. Australia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

16.1. Indonesia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

17.1. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

18.1. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

19.1. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

20.1. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

21.1. UK Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

22.1. Germany Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

23.1. France Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

24.1. Italy Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

25.1. Spain Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

26.1. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

27.1. Russia Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

28.1. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

29.1. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

30.1. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

31.1. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

32.1. Brazil Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

33.1. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

34.1. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Segmentation By Technology or Platform, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Regulatory and Investment Landscape

36. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Landscape And Company Profiles

36.1. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

37. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc

38. Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market

41. Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market High Potential Countries, Segments and Strategies

41.1 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Countries Offering Most New Opportunities

41.2 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Segments Offering Most New Opportunities

41.3 Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Overview Of Key Products - Product Examples
  • Table 2: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Supply Chain Analysis
  • Table 4: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Raw Material Providers
  • Table 5: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Resource Providers
  • Table 6: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Manufacturers (Suppliers)
  • Table 7: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Distributors And Channel Partners
  • Table 8: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Key Technologies & Future Trends
  • Table 9: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Trends
  • Table 10: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major End Users
  • Table 11: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - TAM, US$ Billion, 2025
  • Table 15: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Messenger Ribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Deoxyribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Viral Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Protein Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Peptide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Company Scoring Matrix
  • Table 101: Upcoming Startups
  • Table 102: Pfizer Inc. Financial Performance
  • Table 103: Sanofi S.A. Financial Performance
  • Table 104: AstraZeneca PLC Financial Performance
  • Table 105: Thermo Fisher Scientific Inc. Financial Performance
  • Table 106: GSK plc Financial Performance
  • Table 107: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Competitive Benchmarking (In USD Billions)
  • Table 108: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Competitive Dashboard
  • Table 109: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 110: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 111: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Technology or Platform, 2025 – 2030
  • Table 112: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Supply Chain Analysis
  • Figure 4: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Raw Material Providers
  • Figure 5: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Resource Providers
  • Figure 6: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Distributors And Channel Partners
  • Figure 8: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Key Technologies & Future Trends
  • Figure 9: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major Trends
  • Figure 10: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Major End Users
  • Figure 11: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - TAM, US$ Billion, 2025
  • Figure 15: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Messenger Ribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Deoxyribonucleic Acid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Viral Vector Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Protein Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Peptide Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia , Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Technology or Platform, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market - Company Scoring Matrix
  • Figure 101: Upcoming Startups
  • Figure 102: Pfizer Inc. Financial Performance
  • Figure 103: Sanofi S.A. Financial Performance
  • Figure 104: AstraZeneca PLC Financial Performance
  • Figure 105: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 106: GSK plc Financial Performance
  • Figure 107: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Competitive Benchmarking (In USD Billions)
  • Figure 108: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market, Competitive Dashboard
  • Figure 109: Global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 110: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 111: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Technology or Platform, 2025 – 2030
  • Figure 112: Global, Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Genu Recurvatum Market Report 2026 - Global Outlook – By Type (External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)), By Diagnosis (Magnetic Resonance Imaging (MRI), X-Rays, ...

Isotretinoin Drugs Market Report 2026 - Global Outlook – By Form (Capsules, Injection), By Indication Type (Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplas...

Underwater Drone Market Report 2026 - Global Outlook – By Vehicle Control Mode (Remotely Operated Vehicle, Autonomous Underwater Vehicles, Hybrid Vehicles), By Product Type (Micro, Small And Medium, Light Work-Class, Hea...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Frequently Asked Questions

The Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms market was valued at $39.69 billion in 2025, increased to $45.88 billion in 2026, and is projected to reach $82.61 billion by 2030.

The global Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms market is expected to grow at a CAGR of 15.8% from 2026 to 2035 to reach $82.61 billion by 2035.

Some Key Players in the Messenger Ribonucleic Acid (mRNA) And Next-Generation Vaccine Platforms market Include, Pfizer Inc., Sanofi S.A., AstraZeneca PLC, Thermo Fisher Scientific Inc., GSK plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Moderna Inc., BioNTech SE, Novavax Inc., Walvax Biotechnology Co Ltd, Arcturus Therapeutics Inc, Gennova Biopharmaceuticals Ltd, Vaxxas Pty Ltd, Vaxart Inc, Ethris GmbH, The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, eTheRNA Immunotherapies NV, Stemirna Therapeutics Co Ltd, Primrose Bio Inc, Acuitas Therapeutics Inc, and Incepta Vaccine Ltd. .

Major trend in this market includes: Advancements In mRNA And Next-Generation Vaccine Platforms Strengthen COVID-19 Immunization Strategies. For further insights on this market. request a sample here

North America was the largest region in the messenger ribonucleic acid (mRNA) and next-generation vaccine platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) and next-generation vaccine platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us